RAC 0.00% $1.69 race oncology ltd

Pillar 1 - FTO (new thread), page-2985

  1. 63 Posts.
    lightbulb Created with Sketch. 2


    Can someone explain this to me? So its potentially the FTO inhibition characterises of Zantrene that is leading to the heart protection?
    I thought that the heart protection was an entirely separate mechanism of action and had no connection to FTO inhibition?

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.